Friedman Franklin Stuart 4/A
4/A · Deciphera Pharmaceuticals, Inc. · Filed Feb 20, 2020
Insider Transaction Report
Form 4/AAmended
Friedman Franklin Stuart
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-11-25+23,400→ 23,400 totalExercise: $48.44Exp: 2029-11-25→ Common Stock (23,400 underlying)
Footnotes (1)
- [F1]This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. The option will vest in equal monthly installments over a three-year period, subject to a continued service relationship through such dates.